DODEX

Post-LOE

cyanocobalamin

Accord Biopharma

ANDAINJECTIONINJECTABLE

Approved

Sep 1972

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

5/8 — Partial

DODEX (cyanocobalamin) by Accord Biopharma is clinical pharmacology vitamin b 12 is essential to growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis. Approved for anemia. First approved in 1972.

Drug data last refreshed 18h ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY Vitamin B 12 is essential to growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis. Cyanocobalamin is quantitatively and rapidly absorbed from intramuscular and subcutaneous sites of injection; the plasma level of the compound reaches its peak within…

Worked on DODEX at Accord Biopharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (2)

NCT05785585N/ARecruiting

Effect of Methylcobalamin and Cyanocobalamin Consumption on Vitamin B12 Nutritional Status

Started Sep 2023

54 enrolled

Vitamin B12 Nutritional Deficiency

NCT01306123Phase 1Completed

Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration

Started Feb 2011

16 enrolled

Focus: Bioavailability

DODEX

Mechanism of Action

Indications (1)

Clinical Trials (2)